Haemonetics Corporation (NYSE:HAE) previous close was $59.84 while the outstanding shares total 50.85M. The firm has a beta of 0.35, a 12-month trailing P/E ratio
Haemonetics Corporation (NYSE:HAE) Relative Strength Index (RSI) is 36.64, with weekly volatility at 2.66% and ATR at 1.96. The HAE stock’s 52-week price range has
Haemonetics Corporation (NYSE:HAE) has a beta of 0.35, a 12-month trailing P/E ratio of 36.05, and a growth ratio of 3.60. The stock’s Relative Strength
Haemonetics Corporation (NYSE:HAE) shares traded higher over the last trading session, gaining 0.72% on 05/27/21. The shares fell to a low of $54.90 before closing
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
